Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

被引：0

作者：

N C Tebbutt

M M Cummins

T Sourjina

A Strickland

G Van Hazel

V Ganju

D Gibbs

M Stockler

V Gebski

J Zalcberg

机构：

[1] Austin Health,Department of Medical Oncology

[2] PO Box 5555,undefined

[3] Studley Road,undefined

[4] Heidelberg,undefined

[5] Melbourne,undefined

[6] Victoria 3084,undefined

[7] Australia,undefined

[8] National Health and Medical Research Council Clinical Trials Centre,undefined

[9] University of Sydney,undefined

[10] Locked Bag 77,undefined

[11] Camperdown,undefined

[12] Sydney,undefined

[13] New South Wales 1450,undefined

[14] Australia,undefined

[15] Monash Medical Centre,undefined

[16] 246 Clayton Road,undefined

[17] Clayton,undefined

[18] Melbourne,undefined

[19] Victoria 3168,undefined

[20] Australia,undefined

[21] Sir Charles Gairdner Hospital,undefined

[22] Hospital Avenue,undefined

[23] Nedlands,undefined

[24] Perth,undefined

[25] Western Australia 6009,undefined

[26] Australia,undefined

[27] Frankston Hospital,undefined

[28] PO Box 52,undefined

[29] Frankston,undefined

[30] Melbourne,undefined

[31] Victoria 3199,undefined

[32] Australia,undefined

[33] Christchurch Hospital,undefined

[34] 2 Riccarton Avenue,undefined

[35] Addington,undefined

[36] Christchurch,undefined

[37] Canterbury 8011,undefined

[38] New Zealand,undefined

[39] Peter MacCallum Cancer Centre,undefined

[40] St Andrews Place,undefined

[41] East Melbourne,undefined

[42] Melbourne,undefined

[43] Victoria 3002,undefined

[44] Australia,undefined

来源：

British Journal of Cancer | 2010年 / 102卷

关键词：

advanced gastric cancer; advanced oesophageal cancer; cisplatin; 5-fluorouracil; capecitabine; docetaxel;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：475 / 481

页数：6

共 50 条

[21] An AGITG trial - A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel plus /-radio Therapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma
Barbour, A.
Walpole, E.
Mai, G. T.
Chan, H.
Barnes, E.
Watson, D.
Ackland, S.
Wills, V.
Martin, J.
Burge, M.
Karapetis, C.
Shannon, J.
Nott, L.
Gebski, V.
Wilson, K.
Thomas, J.
Lampe, G.
Zalcberg, J.
Simes, J.
Smithers, M.
ANNALS OF ONCOLOGY, 2016, 27
[22] A phase II study of chemoselection with docetaxel, cisplatin, and 5-fluorouracil as a strategy for organ preservation in patients with resectable esophageal cancer (CROC trial).
Katada, Chikatoshi
Hara, Hiroki
Fujii, Hirofumi
Nakajima, Takako Eguchi
Ando, Takayuki
Nomura, Motoo
Kojima, Takashi
Yamashita, Keishi
Yokoyama, Tetsuji
Sakamoto, Yasutoshi
Sasaki, Hiroki
Inoue, Yusuke
Kawakami, Shogo
Ishikawa, Hideki
Hosokawa, Ayumu
Hamamoto, Yasuo
Muto, Manabu
Tahara, Makoto
Koizumi, Wasaburo
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[23] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
Tatsuya Miyazaki
Makoto Sohda
Naritaka Tanaka
Shigemasa Suzuki
Keisuke Ieta
Makoto Sakai
Akihiko Sano
Takehiko Yokobori
Takanori Inose
Masanobu Nakajima
Minoru Fukuchi
Hitoshi Ojima
Hiroyuki Kato
Hiroyuki Kuwano
Cancer Chemotherapy and Pharmacology, 2015, 75 : 449 - 455
[24] Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study
Meng, Changting
Yin, Hongyan
Sun, Zhao
Zhou, Jianfeng
Chen, Shuchang
Bai, Chunmei
Zhao, Lin
TRANSLATIONAL ONCOLOGY, 2014, 7 (02): : 277 - 283
[25] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
Miyazaki, Tatsuya
Sohda, Makoto
Tanaka, Naritaka
Suzuki, Shigemasa
Ieta, Keisuke
Sakai, Makoto
Sano, Akihiko
Yokobori, Takehiko
Inose, Takanori
Nakajima, Masanobu
Fukuchi, Minoru
Ojima, Hitoshi
Kato, Hiroyuki
Kuwano, Hiroyuki
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 449 - 455
[26] Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Kang, Y. -K.
Kang, W. -K.
Shin, D. -B.
Chen, J.
Xiong, J.
Wang, J.
Lichinitser, M.
Guan, Z.
Khasanov, R.
Zheng, L.
Philco-Salas, M.
Suarez, T.
Santamaria, J.
Forster, G.
McCloud, P. I.
ANNALS OF ONCOLOGY, 2009, 20 (04) : 666 - 673
[27] PHASE-II STUDY OF WEEKLY 5-FLUOROURACIL, CISPLATIN AND VINBLASTINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
ODWYER, PJ
LANGER, CJ
WALCZAK, J
LEVY, MH
PADAVICSHALLER, K
HUDES, GR
LITWIN, S
COMIS, RL
EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1589 - 1593
[28] Weekly Docetaxel, Cisplatin, and 5-Fluorouracil as Initial Therapy for Patients With Advanced Gastric and Esophageal Cancer
Overman, Michael J.
Kazmi, Syed M.
Jhamb, Jagriti
Lin, E.
Yao, James C.
Abbruzzese, James L.
Ho, Linus
Ajani, Jaffer
Phan, Alexandria
CANCER, 2010, 116 (06) : 1446 - 1453
[29] Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: A non-comparative randomized phase II trial
Ducreux, Michel
Giovannini, Marc
Baey, Charlotte
Llacer, Carmen
Bennouna, Jaafar
Adenis, Antoine
Peiffert, Didier
Mornex, Francoise
Abbas, Moncef
Boige, ValSrie
Pignon, Jean-Pierre
Conroy, Thierry
Cellier, Patrice
Juzyna, Beata
Viret, Frederic
DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) : 950 - 955
[30] Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer
Novarino, A
Chiappino, I
Bertelli, GF
Heouaine, A
Ritorto, G
Addeo, A
Bellone, G
Merlano, M
Bertetto, O
ANNALS OF ONCOLOGY, 2004, 15 (03) : 474 - 477

← 1 2 3 4 5 →